Chapter 15: Pediatric Oncology Flashcards
Less than ___ of cancers happen in children.
1%
Top 3 most common types of childhood cancers.
Leukemia, brain and nervous system, and neuroblastoma
What are some of the adverse side effects of cancer and its treatments?
Anorexia, diminished immune response, disturbed drug metabolism, delayed/compromized wound healing, reduced quality of life, reduced treatment response, reduced survival
Why are children more susceptible to malnutrition and protein depletion during cancer treatment?
Because of rapid growth, smaller reserves, higher relative needs per weight, and greater Resting Energy Expenditure
For what reasons are children more susceptible to malnutrition and protein depletion?
Because of rapid growth, smaller reserves, higher relative needs per weight and greater resting energy expenditure (REE)
Which assessment tool has been modified and validated for use in children?
Subjective Global Assessment (SGA) - renamed to Subjective Global Nutrition Assessment
What is cachexia
The loss of both lean and fat mass seen in the context of an illness, including cancer.
In children, what is the hallmark outcome of cachexia?
growth failure (as the result of anorexia, inflammation, and altered carbohydrate, fat and protein metabolism)
In cachexia, ____ accelerates, contributing to muscle breakdown.
protein turnover
What is the equation for catch-up growth?
kcal/kg x Ideal wt (kg) divided by kcal/day x Actual wt (kg)
What are two micronutrients of concern for pediatric oncology patients?
Calcium and Vitamin D because a child’s bone health may be compromised during the course of cancer treatment.
Breast milk is low in ____.
Vitamin D.
All exclusively breast-fed infants should receive which supplement?
400 IU Vitamin D/day
What are some chemotherapy-related consequences in pediatric patients?
GI side effects
Radiation-related consequences in pediatric patients?
Diarrhea, mucositis, nausea/vomiting, fatigue, poor appetite. Long-term consequences include cognitive impairment, altered bone development, learning and hearing impairments, neuroendocrine problems and secondary malignancies.